Search company, investor...
Search

Predict your next investment

Venture Capital
gthcap.com

See what CB Insights has to offer

Investments

19

Portfolio Exits

2

Partners & Customers

1

Service Providers

1

About GT Healthcare Capital Partners

GT Healthcare Capital Partners is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology landscapes. GT Healthcare intends to provide capital and scale expertise to healthcare businesses in Asia / Greater China.

GT Healthcare Capital Partners Headquarters Location

Room 403, 4/F Nan Fung Tower 88 Connaught Road Central

Central,

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest GT Healthcare Capital Partners News

Oxford VR secures £10m to expand immersive therapy

Feb 17, 2020

Immersive clinical technology start-up Oxford VR has closed a £10m Series A funding round led by Optum Ventures and supported by Luminous Ventures. The investment was also supported by previous backers, Oxford Sciences Innovation, Oxford University Innovation and GT Healthcare Capital Partners. Oxford VR was founded in 2017, building upon the research of Daniel Freeman, Professor of Clinical Psychology at Oxford University and Consultant Clinical Psychologist at Oxford Health NHS Foundation Trust. Its automated treatments use virtual reality (VR) technology and a virtual coach to create simulations of the scenarios in which psychological difficulties occur. To date the technology has been used to treat fear of heights and boost social engagement, but Oxford VR intends to cover a wider range of psychological disorders, particularly those that are most complex and costly to treat. Findings from a large randomised controlled trial, which was published in The Lancet Psychiatry journal, demonstrated that Oxford VR’s technology was highly effective for reduction of fear of heights. The company is also participating in the gameChange project, which with over 400 NHS patients across England, represents the largest ever clinical trial of VR for mental health disorders. Outside of the UK it is working on trials with AXA Hong Kong and The Chinese University of Hong Kong in Asia, and the National Mental Health Innovation Centre in the US. The latest investment in Oxford VR, which follows a £3.2m round in 2018, will be used to accelerate its US expansion and to continue expansion of its treatment pipeline. With the NHS planning to spend c.£12bn on mental health in 2019-20, access to mental health services in high demand and therapists in short supply, we expect to see this part of the HealthTech market expand rapidly over the next few years.

GT Healthcare Capital Partners Investments

19 Investments

GT Healthcare Capital Partners has made 19 investments. Their latest investment was in Autobahn Therapeutics as part of their Series C on September 9, 2022.

CBI Logo

GT Healthcare Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/8/2022

Series C

Autobahn Therapeutics

$32.7M

Yes

8

6/7/2022

Series A

Moon Surgical

$31.3M

Yes

6

1/14/2022

Seed VC - II

Shinevia

Yes

4

4/28/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/27/2021

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/8/2022

6/7/2022

1/14/2022

4/28/2021

4/27/2021

Round

Series C

Series A

Seed VC - II

Series B

Series D

Company

Autobahn Therapeutics

Moon Surgical

Shinevia

Subscribe to see more

Subscribe to see more

Amount

$32.7M

$31.3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

6

4

10

10

GT Healthcare Capital Partners Portfolio Exits

2 Portfolio Exits

GT Healthcare Capital Partners has 2 portfolio exits. Their latest portfolio exit was Exscientia on October 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/1/2021

IPO

$99M

Public

3

9/30/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2021

9/30/2021

Exit

IPO

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

3

10

GT Healthcare Capital Partners Partners & Customers

1 Partners and customers

GT Healthcare Capital Partners has 1 strategic partners and customers. GT Healthcare Capital Partners recently partnered with Exscientia on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/11/2019

Partner

United Kingdom

Exscientia expands international collaborations with Shanghai-headquartered GT Apeiron Therapeutics — Exscientia Ltd

Oxford , UK , 11th June 2019 : Exscientia , a world-leading Artificial Intelligence - driven drug discovery company , announced today that it has entered an AI drug discovery partnership with Shanghai-headquartered GT Apeiron Therapeutics .

1

Date

6/11/2019

Type

Partner

Business Partner

Country

United Kingdom

News Snippet

Exscientia expands international collaborations with Shanghai-headquartered GT Apeiron Therapeutics — Exscientia Ltd

Oxford , UK , 11th June 2019 : Exscientia , a world-leading Artificial Intelligence - driven drug discovery company , announced today that it has entered an AI drug discovery partnership with Shanghai-headquartered GT Apeiron Therapeutics .

Sources

1

GT Healthcare Capital Partners Service Providers

1 Service Provider

GT Healthcare Capital Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

GT Healthcare Capital Partners Team

1 Team Member

GT Healthcare Capital Partners has 1 team member, including current Founder, Managing Partner, Alan Au.

Name

Work History

Title

Status

Alan Au

Deutsche Bank, JAFCO Asia, Morningside Venture Partners, and KPMG

Founder, Managing Partner

Current

Name

Alan Au

Work History

Deutsche Bank, JAFCO Asia, Morningside Venture Partners, and KPMG

Title

Founder, Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.